| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000032752 |
| Receipt No. | R000037354 |
| Official scientific title of the study | Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study- |
| Date of disclosure of the study information | 2018/05/29 |
| Last modified on | 2018/10/05 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Suppressive effect of test food on the postprandial triglyceride level -A randomized, double blind, placebo controlled, cross-over study- | |
| Title of the study (Brief title) | Suppressive effect of combination of test food on the postprandial triglyceride level | |
| Region |
|
|
| Condition | ||
| Condition | None | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of test food on the postprandial triglyceride level of subjects. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Area under the curve for postprandial serum triglyceride level |
| Key secondary outcomes | Area under the curve for Remnant-like particle cholesterol, and serum triglyceride levels and Remnant-like particle cholesterol of before, 2, 3, 4 and 6 hours after high fat meal ingestion. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of test food, and then ingestion of placebo after wash out period. | |
| Interventions/Control_2 | Intake of placebo, and then ingestion of test food after wash out period. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Males and females 20 to 64 years of age.
2)Subjects whose fasting serum triglyceride levels are less than 200 mg/dL. |
|||
| Key exclusion criteria | 1)Subjects who has serious medical history or who had digestive tract resection surgery.
2)Subjects who routinely use medicine, supplements, FOSHU and/or health food which affect to result of the study. 3)Subjects who have allergy to the test food or high fat meal and have extreme lactose intolerance or diarrhea. 4)Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating. 5) Heavy use of alcohol or excessive smokers 6) Subjects who is considered to be inappropriate to attend the present study by the investigator. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Hideaki Hoshino |
| Organization | Medical Corporation Jikokai Shiroishi Internal Medicine Clinic |
| Division name | General Medicine Clinical Departments Internal Medicine Respiratory Medicine Allergy |
| Address | 7-10-30 Chuo-1 jo, Shiroishi-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-868-2711 |
| shiroishi@jikkai.or.jp | |
| Public contact | |
| Name of contact person | Kosuke Suzuki |
| Organization | Medical Corporation Jikokai |
| Division name | Clinical Trial Division |
| Address | 7-10-30 Chuo-1 jo, Shiroishi-ku, Sapporo, Hokkaido, Japan |
| TEL | 011-868-2711 |
| Homepage URL | |
| suzuki-jikoukai@e-mail.jp | |
| Sponsor | |
| Institute | FANCL Corporation
Research Institute |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人社団 慈昂会 白石内科クリニック |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037354 |